Friedl Sinnaeve

420 total citations
17 papers, 260 citations indexed

About

Friedl Sinnaeve is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Friedl Sinnaeve has authored 17 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Rheumatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Friedl Sinnaeve's work include Sarcoma Diagnosis and Treatment (11 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Vascular Tumors and Angiosarcomas (3 papers). Friedl Sinnaeve is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Bone Tumor Diagnosis and Treatments (5 papers) and Vascular Tumors and Angiosarcomas (3 papers). Friedl Sinnaeve collaborates with scholars based in Belgium, United States and Netherlands. Friedl Sinnaeve's co-authors include Czar Louie Gaston, R. J. Grimer, Krishna Reddy, S. R. Carter, Raf Sciot, Maria Dêbiec‐Rychter, Daphne Hompes, Geoffroy Vandeputte, Patrick Schöffski and Daniel J. García-Domínguez and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Orthopaedics and Related Research.

In The Last Decade

Friedl Sinnaeve

17 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Friedl Sinnaeve Belgium	8	147	102	63	54	54	17	260
Armelle Vinceneux France	8	103 0.7×	110 1.1×	32 0.5×	66 1.2×	17 0.3×	28	263
Kazumasa Nishimoto Japan	10	163 1.1×	108 1.1×	148 2.3×	70 1.3×	23 0.4×	27	372
Antoinette B. Thomas United States	8	91 0.6×	78 0.8×	72 1.1×	64 1.2×	21 0.4×	18	289
Shunichi Toki Japan	11	139 0.9×	70 0.7×	55 0.9×	53 1.0×	18 0.3×	41	293
Alberto G. Ayala United States	4	155 1.1×	162 1.6×	81 1.3×	39 0.7×	38 0.7×	4	283
Guillaume Dachy Belgium	6	64 0.4×	93 0.9×	61 1.0×	51 0.9×	18 0.3×	14	216
Patrizio Caldora Italy	11	165 1.1×	116 1.1×	57 0.9×	76 1.4×	11 0.2×	25	346
Hirotaka Yonezawa Japan	10	151 1.0×	93 0.9×	47 0.7×	85 1.6×	12 0.2×	42	257
Olga Torre Italy	14	344 2.3×	110 1.1×	46 0.7×	73 1.4×	24 0.4×	24	560
Thomas H. Temple United States	11	290 2.0×	203 2.0×	110 1.7×	121 2.2×	34 0.6×	16	438

Countries citing papers authored by Friedl Sinnaeve

Since Specialization

Citations

This map shows the geographic impact of Friedl Sinnaeve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedl Sinnaeve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedl Sinnaeve more than expected).

Fields of papers citing papers by Friedl Sinnaeve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedl Sinnaeve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedl Sinnaeve. The network helps show where Friedl Sinnaeve may publish in the future.

Co-authorship network of co-authors of Friedl Sinnaeve

This figure shows the co-authorship network connecting the top 25 collaborators of Friedl Sinnaeve. A scholar is included among the top collaborators of Friedl Sinnaeve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedl Sinnaeve. Friedl Sinnaeve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sciot, Raf, et al.. (2025). Keratin Positive Giant Cell Rich Tumor of the Pelvic Bone with a HMGA2::NCOR2 Fusion: A Case Report. International Journal of Surgical Pathology. 33(5). 1267–1270. 1 indexed citations

Claerhout, Sofie, Sara Vander Borght, Lien Spans, et al.. (2024). Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours. The Journal of Pathology Clinical Research. 10(3). e12376–e12376. 1 indexed citations

Dewaele, Barbara, Maria Dêbiec‐Rychter, Raf Sciot, et al.. (2024). Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes. Journal of Molecular Diagnostics. 26(5). 374–386. 2 indexed citations

Wafa, Hazem, et al.. (2021). Intraosseous schwannoma of the glenoid: case report and literature review. SICOT-J. 7. 2–2. 2 indexed citations

Sciot, Raf, et al.. (2021). An egg in the leg: Case report of an osteochondrolipoma. SICOT-J. 7. 59–59. 2 indexed citations

Kyriazoglou, Anastasios, Annouschka Laenen, Herlinde Dumez, et al.. (2021). Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients. Oncology Research and Treatment. 44(5). 232–241. 2 indexed citations

Schöffski, Patrick, Daphne Hompes, M. Stas, et al.. (2020). Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis. Sarcoma. 2020. 1–9. 23 indexed citations

Cornillie, Jasmien, Agnieszka Woźniak, Haifu Li, et al.. (2019). Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing. Molecular Cancer Therapeutics. 18(6). 1168–1178. 27 indexed citations

Schöffski, Patrick, Jasmien Cornillie, Yemarshet K. Gebreyohannes, et al.. (2019). XenoSarc: A comprehensive platform of patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) for early drug testing.. Journal of Global Oncology. 5(suppl). 37–37. 2 indexed citations

10.

Clément, Paul M., Oliver Bechter, Herlinde Dumez, et al.. (2017). Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma. Sarcoma. 2017. 1–7. 1 indexed citations

11.

Morren, Marie‐Anne, et al.. (2017). Successful forearm prosthesis fitting in a patient with epidermolysis bullosa dystrophica. Prosthetics and Orthotics International. 42(3). 254–257. 1 indexed citations

12.

Sleurs, Charlotte, Veerle Labarque, Catharina Dhooge, et al.. (2017). The Role of theMTHFRC677T Polymorphism in Methotrexate-Induced Toxicity in Pediatric Osteosarcoma Patients. Pharmacogenomics. 18(8). 787–795. 19 indexed citations

13.

Li, Haifu, Jasmien Cornillie, Agnieszka Woźniak, et al.. (2015). Abstract 1460: Establishment and characterization of a panel of patient-derived soft tissue sarcoma (STS) xenograft models for in vivo testing of novel therapeutic approaches. Cancer Research. 75(15_Supplement). 1460–1460. 21 indexed citations

14.

Reddy, Krishna, Friedl Sinnaeve, Czar Louie Gaston, R. J. Grimer, & S. R. Carter. (2014). Aneurysmal Bone Cysts: Do Simple Treatments Work?. Clinical Orthopaedics and Related Research. 472(6). 1901–1910. 65 indexed citations

15.

Samson, Ignace, et al.. (2012). Perineural spread of endometriosis along the obturator nerve into the adductor thigh compartment. Japanese Journal of Radiology. 30(5). 446–449. 9 indexed citations

16.

Mackintosh, Carlos, José Luis Ordóñez, Daniel J. García-Domínguez, et al.. (2011). 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene. 31(10). 1287–1298. 70 indexed citations

17.

Sinnaeve, Friedl & Geoffroy Vandeputte. (2008). Clinical outcome of surgical intervention for recalcitrant infero-medial heel pain.. PubMed. 74(4). 483–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact